ORAL CAVITY CANCER
Clinical trials for ORAL CAVITY CANCER explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CANCER trials appear
Sign up with your email to follow new studies for ORAL CAVITY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 adults with advanced head and neck cancer that had spread or come back. The goal was to see if the combo could shrink tumors or slow the disease. Patients were grouped based on whether they had tried…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
Immunotherapy combo shows promise in advanced head and neck cancer trial
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation is safe and effective for people with advanced head and neck cancer. 59 participants received the combination, starting with a pembrolizumab dose one week before chemoradi…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated May 26, 2026 08:59 UTC